Ply Chichareon

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 785 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes

Mariusz Tomaniak, Ply Chichareon, Yoshinobu Onuma et al. · JAMA Cardiology · 2019 · 134 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial

Patrick W. Serruys, Kuniaki Takahashi, Ply Chichareon et al. · European Heart Journal · 2019 · 127 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD

Carlos Collet, Yosuke Miyazaki, Nicola Ryan et al. · Journal of the American College of Cardiology · 2018 · 119 citations · Full text

Medicine, Cardiology, Radiology +12

Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease

Norihiro Kogame, Kuniaki Takahashi, Mariusz Tomaniak et al. · JACC: Cardiovascular Interventions · 2019 · 113 citations

Medicine, Cardiology, Clinical Sciences +17